Biotech's Former Brass Fights SEC Efforts To Get Court Wins
Attorneys for the former CEO and CFO of biotechnology company Osiris Therapeutics Inc. on Monday tried to rebuff the U.S. Securities and Exchange Commission's efforts to secure partial judgments against them,...To view the full article, register now.
Already a subscriber? Click here to view full article